Buscar | Mạng xã hội kotra-hanoi.org.vn

KUMUD SINGH agrega un archivo Health
2026-03-31 12:19:37 -

All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

0 Commentarios 0 Acciones 1777 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-31 12:27:43 -

All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%
According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...

0 Commentarios 0 Acciones 1756 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-27 12:52:30 -

Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...

0 Commentarios 0 Acciones 1601 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-04-08 13:01:20 -

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Commentarios 0 Acciones 879 Views

Please log in to like, share and comment!
Sia Snowman agrega un archivo Networking
2026-05-05 13:06:03 -

Cancer Therapeutics Market Trends in Middle East GCC
The GCC Cancer Therapeutics Market Outlook (2021-2031) reflects a steadily advancing healthcare sector driven by rising cancer prevalence, increasing healthcare expenditure, and strong government initiatives aimed at improving treatment accessibility. The Gulf Cooperation Council (GCC) region—including Saudi Arabia, the UAE, Qatar, Kuwait, Oman, and Bahrain—is...

0 Commentarios 0 Acciones 334 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-24 11:55:47 -

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Commentarios 0 Acciones 1640 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-24 11:59:58 -

Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%
According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...

0 Commentarios 0 Acciones 1485 Views

Please log in to like, share and comment!
Karls Scott agrega un archivo Health
2026-02-05 06:36:06 -

Chemiluminescence Immunoassay in Oncology and Biomarker Analysis
Evolving Trends Shaping Chemiluminescence Immunoassay Technologies Chemiluminescence immunoassay has become a cornerstone of modern diagnostic testing, valued for its high sensitivity, broad dynamic range, and ability to deliver rapid, reproducible results. As clinical laboratories face increasing test volumes and demand for precision, this technology continues to evolve, supported by advances...

0 Commentarios 0 Acciones 1971 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-04-09 09:45:40 -

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

0 Commentarios 0 Acciones 1027 Views

Please log in to like, share and comment!
KUMUD SINGH agrega un archivo Health
2026-03-31 10:32:48 -

GVHD Treatment Market to Reach USD 2.1 Billion by 2031 | CAGR 8.5%
According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031. Graft versus Host Disease, a serious complication following stem cell or bone...

0 Commentarios 0 Acciones 1383 Views

Please log in to like, share and comment!

Resultados de la búsqueda